Keson-Brookes Maiken — SEC Form 4 filings

SEC reporting owner CIK 1693805. 7 Form 4 filings on record with FilingPulse; latest filed 2025-12-05.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-03-04 to 2025-12-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mural Oncology plc (MURA)Chief Legal Officer76 legs · 12,173 sh · $36,7498

Form 4 filings — Keson-Brookes Maiken

FiledFormIssuerReported transactionsSource
2025-12-054Mural Oncology plc (MURA)Disposition to issuer (D): 68,834 · Disposition to issuer (D): 54,242 (derivative) · Disposition to issuer (D): 31,200 (derivative) · Disposition to issuer (D): 65,000 (derivative)EDGAR
2025-07-234Mural Oncology plc (MURA)Sale (S): 2,572 @ $2.48EDGAR
2025-07-224Mural Oncology plc (MURA)Sale (S): 2,158 @ $2.48EDGAR
2025-03-054Mural Oncology plc (MURA)Grant/award (A): 35,000 @ $0 · Sale (S): 1,262 @ $3.36 · Sale (S): 1,469 @ $3.45 · Grant/award (A): 65,000 (derivative) @ $0EDGAR
2024-12-264Mural Oncology plc (MURA)Sale (S): 2,555 @ $3.27EDGAR
2024-07-184Mural Oncology plc (MURA)Sale (S): 2,157 @ $3.41EDGAR
2024-03-044Mural Oncology plc (MURA)Grant/award (A): 16,800 @ $0 · Grant/award (A): 31,200 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1693805 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →